CASP3 and in situ carcinoma: Administration of kinetin 1 mg/kg in CIS-treated rats showed a potent antiapoptotic effect evident by a significant decrease in caspase-3 expression compared to CIS+ 0.25 Kn and CIS+ Vit C.